Newsroom | 12204 results

NEW DELHI--(BUSINESS WIRE)--Fortis Healthcare vient de recevoir six prix prestigieux au FICCI Advantage Healthcare India 2026, le sommet international sur les voyages médicaux , soulignant son leadership et son excellence dans la prestation de soins de santé à l'échelle mondiale. Ces distinctions, présentées lors du sommet de trois jours qui s’est tenu du 23 au 25 février 2026 dans le cadre des FICCI Medical Value Travel Awards, consolident la réputation de Fortis en tant que partenaire de conf...

ORLANDO, Fla.--(BUSINESS WIRE)--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers. As part of these discussions, Imaginostics and Siemens Healthineers intend to continue dialogue concerning potential technical and commercial pathways for Imaginostics’ envisioned ImagiView™ and ImagiSight™ offerings and their potential...

NEW DELHI--(BUSINESS WIRE)--Fortis Healthcare has been honored with six prestigious awards at the FICCI Advantage Healthcare India, International Summit on Medical Value Travel....

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA). The System utilizes proximal hypoglossal nerve stimulation (p-HGNS), a differentiated neurostimulation modality, to treat OSA in patients with an apnea-hypopnea index (AHI) between 15 and 65...

LINCOLN, Neb. & ATLANTA--(BUSINESS WIRE)--Piedmont, a Georgia-based healthcare system with nationally-ranked clinical programs, has named NRC Health, the leader in healthcare experience management, as its new strategic experience partner to support the organization’s mission-driven growth and commitment to making a positive difference in every life it touches. The enterprise-wide partnership is designed to elevate the patient, family, employee, and consumer experience across Piedmont’s expansiv...

HOUSTON & PANAMA CITY, Panama--(BUSINESS WIRE)--XCath announced successful completion of world’s first telerobotic mechanical thrombectomy for stroke using the XCath Iris Surgical Robotic System....

MEDOLLA, Italy & PLYMOUTH, Mich.--(BUSINESS WIRE)--Eurosets is pleased to announce the official start of U.S. commercialization for the Trilly and Horizon oxygenators, following successful FDA 510(k) clearance. This milestone reflects our commitment to supporting clinicians with reliable, high-performance technologies at a time when the U.S. healthcare system continues to face a critical and growing need for oxygenators and life-support solutions. Equipped with an integrated stainless-steel hea...

SALT LAKE CITY--(BUSINESS WIRE)--The addition of APEXecm reflects Kolosis's continued commitment to developing and commercializing best-in-class solutions for the surgical community....

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s CEO, Brent Ashton, with a Question and Answ...

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study to confirm the safety and efficacy of abenacianine to visualize tumors during lung cancer surgery. Abenacianine is an investigational tumor-activated, intraoperative imaging agent designed to illuminate malignant tissue in patients undergoing surgery for suspected or c...